CNS Pharmaceuticals (CNSP) Competitors $0.12 -0.01 (-7.44%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CNSP vs. ADMP, CPIX, PULM, BIVI, CLDI, GOVX, MRKR, LPCN, PLUR, and LGVNShould you be buying CNS Pharmaceuticals stock or one of its competitors? The main competitors of CNS Pharmaceuticals include Adamis Pharmaceuticals (ADMP), Cumberland Pharmaceuticals (CPIX), Pulmatrix (PULM), BioVie (BIVI), Calidi Biotherapeutics (CLDI), GeoVax Labs (GOVX), Marker Therapeutics (MRKR), Lipocine (LPCN), Pluri (PLUR), and Longeveron (LGVN). These companies are all part of the "medical" sector. CNS Pharmaceuticals vs. Adamis Pharmaceuticals Cumberland Pharmaceuticals Pulmatrix BioVie Calidi Biotherapeutics GeoVax Labs Marker Therapeutics Lipocine Pluri Longeveron CNS Pharmaceuticals (NASDAQ:CNSP) and Adamis Pharmaceuticals (NASDAQ:ADMP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Which has higher valuation & earnings, CNSP or ADMP? CNS Pharmaceuticals has higher earnings, but lower revenue than Adamis Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCNS PharmaceuticalsN/AN/A-$18.85M-$74.970.00Adamis Pharmaceuticals$4.76M0.00-$26.48MN/AN/A Which has more risk & volatility, CNSP or ADMP? CNS Pharmaceuticals has a beta of 2.58, indicating that its stock price is 158% more volatile than the S&P 500. Comparatively, Adamis Pharmaceuticals has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Does the media prefer CNSP or ADMP? In the previous week, CNS Pharmaceuticals had 3 more articles in the media than Adamis Pharmaceuticals. MarketBeat recorded 3 mentions for CNS Pharmaceuticals and 0 mentions for Adamis Pharmaceuticals. Adamis Pharmaceuticals' average media sentiment score of 0.00 beat CNS Pharmaceuticals' score of -0.11 indicating that Adamis Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment CNS Pharmaceuticals Neutral Adamis Pharmaceuticals Neutral Is CNSP or ADMP more profitable? CNS Pharmaceuticals has a net margin of 0.00% compared to Adamis Pharmaceuticals' net margin of -502.73%. CNS Pharmaceuticals' return on equity of 0.00% beat Adamis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets CNS PharmaceuticalsN/A N/A -515.32% Adamis Pharmaceuticals -502.73%-420.53%-256.87% Does the MarketBeat Community favor CNSP or ADMP? Adamis Pharmaceuticals received 287 more outperform votes than CNS Pharmaceuticals when rated by MarketBeat users. However, 71.21% of users gave CNS Pharmaceuticals an outperform vote while only 59.75% of users gave Adamis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCNS PharmaceuticalsOutperform Votes4771.21% Underperform Votes1928.79% Adamis PharmaceuticalsOutperform Votes33459.75% Underperform Votes22540.25% Do analysts rate CNSP or ADMP? CNS Pharmaceuticals currently has a consensus target price of $0.50, indicating a potential upside of 301.93%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe CNS Pharmaceuticals is more favorable than Adamis Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CNS Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Adamis Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in CNSP or ADMP? 14.0% of CNS Pharmaceuticals shares are owned by institutional investors. Comparatively, 38.6% of Adamis Pharmaceuticals shares are owned by institutional investors. 0.1% of CNS Pharmaceuticals shares are owned by company insiders. Comparatively, 1.3% of Adamis Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryCNS Pharmaceuticals beats Adamis Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get CNS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNSP vs. The Competition Export to ExcelMetricCNS PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.15M$7.00B$5.38B$8.84BDividend YieldN/A8.11%5.13%4.09%P/E Ratio0.0011.01105.9717.81Price / SalesN/A388.961,243.81162.56Price / CashN/A52.5940.2936.29Price / Book1.2410.377.086.50Net Income-$18.85M$153.60M$119.58M$226.22M7 Day Performance18.36%4.59%2.25%4.04%1 Month Performance-11.77%-6.28%-2.33%4.94%1 Year Performance-99.89%33.39%33.91%29.30% CNS Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNSPCNS Pharmaceuticals1.6023 of 5 stars$0.12-7.4%$0.50+301.9%-99.9%$7.15MN/A0.005Gap DownADMPAdamis PharmaceuticalsN/AN/AN/AN/A$7.26M$4.76M0.0011Gap DownCPIXCumberland Pharmaceuticals0.4591 of 5 stars$1.06-1.9%N/A-38.7%$14.88M$39.55M-1.3880High Trading VolumePULMPulmatrix0.2746 of 5 stars$6.12+0.2%N/A+230.8%$22.35M$10.01M-2.3220BIVIBioVie1.3671 of 5 stars$3.05-1.9%$4.00+31.1%-37.2%$28.46MN/A-0.2710CLDICalidi Biotherapeutics2.5503 of 5 stars$2.15flat$16.67+675.2%N/A$28.12M$50,000.000.0041Gap DownHigh Trading VolumeGOVXGeoVax Labs2.793 of 5 stars$2.95+9.3%$13.25+349.2%-61.5%$27.84M$3.09M0.0017Analyst RevisionMRKRMarker Therapeutics3.5384 of 5 stars$3.10+5.1%$19.00+512.9%+15.7%$27.66M$3.31M0.0060LPCNLipocine2.0526 of 5 stars$5.15+3.0%$10.00+94.2%+108.5%$27.54M$7.92M-6.7810Analyst ForecastPLURPluri0.0799 of 5 stars$4.90+4.3%N/A-1.2%$27.24M$330,000.00-0.81150Gap UpLGVNLongeveron1.7732 of 5 stars$1.89+1.1%$8.00+323.3%-90.1%$27.14M$710,000.00-0.3023 Related Companies and Tools Related Companies ADMP Competitors CPIX Competitors PULM Competitors BIVI Competitors CLDI Competitors GOVX Competitors MRKR Competitors LPCN Competitors PLUR Competitors LGVN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CNSP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNSP Stock Alerts